The Hydrocephalus Association (HA) is funding the best and brightest. Since 2009, HA has spent $7.8 million on our research programs. Our researchers have then gone on to secure over $19 million in additional funding to continue their innovative work.
Kristopher Kahle, MD, PhD is our latest success story. Dr. Kahle was awarded the Innovator Award for Posthemorrhagic Hydrocephalus (PHH) in 2016 and the Innovator Award for Postinfectious Hydrocephalus (PIH) in 2017.
This year Dr. Kahle received a National Institutes of Health (NIH) grant worth $1.8 million over five years. This funding will allow Dr. Kahle and his research team to dig deeper into new theories on why posthemorrhagic and postinfectious hydrocephalus develop and test drugs to prevent or minimize hydrocephalus after a brain bleed or infection.
Read the full article here.